<DOC>
	<DOCNO>NCT02869867</DOCNO>
	<brief_summary>Nursing study , prospective , randomize , two-center open-label . Patients randomize two group first lay Qutenza® : - Patients receive lay Qutenza® without refrigerate cushion - Patients receive lay Qutenza® associate refrigerate cushion The objective study evaluate effectiveness application cold reduction pain ( burn ) one hour patch installation high concentration capsaicin ( Qutenza® ) patient localize neuropathic pain .</brief_summary>
	<brief_title>Does Application Cold Decreases Pain Associated Pose Patch Capsaicine High Concentration Carrier Patients Localized Neuropathic Pains ? - DIDOCAP</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Major Do oppose participation study Monitoring case localize neuropathic pain Diagnostic neuropathic pain score ≥ 4 Neuropathic pain conventional treatment failure firstline Front advantage lay first patch Qutenza® With ability understand propose study Patch Installation foot , face , mucous membrane Eutectic mixture local anesthetic ( EMLA ) Pose premedication Having Already receive prior installation patch Qutenza® Allergy component Qutenza® Known poorly stabilize hypertension Known cryoglobulinaemia Pregnant lactate woman Patient enjoy measure legal protection ( guardianship , guardianship ... ) Private Patient freedom No affiliation social security scheme . Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>